Showing results (1-10 of 258) with videos related to
Sort By:
Pageof 26
The American Journal of Psychiatry|May 1, 1982
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophreniaJ Hirschowitz, F P Zemlan, D L GarverPsychiatry Research|April 1, 1984
Mood-incongruent versus mood-congruent psychosis: differential antipsychotic response to lithium therapyF P Zemlan, J Hirschowitz, D L GarverArchives of General Psychiatry|December 1, 1986
Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patientsF P Zemlan, J Hirschowitz, D L GarverBiological Psychiatry|June 1, 1987
Growth hormone response to apomorphine and family patterns of illnessF Sautter, D L Garver, F P Zemlan, et al.Psychiatry Research|July 1, 1986
Relationship of psychotic symptom clusters in schizophrenia to neuroleptic treatment and growth hormone response to apomorphineF P Zemlan, J Hirschowitz, F Sautter, et al.The American Journal of Psychiatry|November 1, 1985
Down-regulation of central dopamine receptors in schizophreniaF P Zemlan, R J Hitzemann, J Hirschowitz, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophreniaF P Zemlan, J Hirschowitz, F J Sautter, et al.Psychopharmacology|January 1, 1986
Fluphenazine activity and antipsychotic responseR J Hitzemann, D L Garver, M Mavroidis, et al.Biological Psychiatry|May 1, 1986
Growth hormone response to apomorphine and diagnosis: a comparison of three diagnostic systemsJ Hirschowitz, F P Zemlan, R J Hitzemann, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Depression and antidepressant therapy: receptor dynamicsF P Zemlan, D L GarverPageof 26